Literature DB >> 27784558

The Incidence, Prevalence, and Natural History of Erectile Dysfunction.

Ian Eardley1.   

Abstract

Over the past 20 years, there have been numerous reports on the epidemiology of erectile dysfunction (ED). Most studies have reported prevalence rates in a variety of different populations using a variety of methodologies and a variety of definitions of ED. The varying methodologies, definitions, and populations make comparison difficult, but in high-quality studies there is a consistent association with age, and analytical studies suggest an association with cardiovascular risk factors, depression, and lower urinary tract symptoms. There is emerging evidence of a link with smoking and obesity. A smaller number of studies have reported the incidence of ED, again using a variety of different methodologies, definitions, and study populations. While the methodological differences were again prominent, there was a consistent correlation with increasing age. Only two reports have studied the natural history of ED, and both demonstrated not only that there was commonly disease progression, but also that in some men there was remission of ED. Remission was commoner in younger men, suggesting that in these men psychological and lifestyle factors might be the cause of temporary self-limiting ED. These studies also suggest that lifestyle modifications might be helpful in the prevention and treatment of ED. Eardley I. The incidence, prevalence, and natural history of erectile dysfunction. Sex Med Rev 2013;1:3-16.
Copyright © 2013, International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiology; Erectile Dysfunction; Incidence; Natural History; Prevalence

Year:  2015        PMID: 27784558     DOI: 10.1002/smrj.2

Source DB:  PubMed          Journal:  Sex Med Rev        ISSN: 2050-0521


  18 in total

1.  Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis.

Authors:  Camilla R Madeira; Fernanda S Tonin; Mariana M Fachi; Helena H Borba; Vinicius L Ferreira; Leticia P Leonart; Aline F Bonetti; Rogerio P Moritz; Angela C L B Trindade; Alan G Gonçalves; Fernando Fernandez-Llimos; Roberto Pontarolo
Journal:  World J Urol       Date:  2020-05-09       Impact factor: 4.226

2.  Comorbidities of male patients with sexual dysfunction in a psychiatry clinic: A study on industrial employees.

Authors:  Jnanamay Das; Shailly Yadav
Journal:  Ind Psychiatry J       Date:  2022-01-05

Review 3.  Erectile dysfunction and risk of cardiovascular and all-cause mortality in the general population: a meta-analysis of cohort studies.

Authors:  Yu Fan; Binbin Hu; Changfeng Man; Feilun Cui
Journal:  World J Urol       Date:  2018-05-03       Impact factor: 4.226

Review 4.  Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction.

Authors:  Biljana Musicki; Anthony J Bella; Trinity J Bivalacqua; Kelvin P Davies; Michael E DiSanto; Nestor F Gonzalez-Cadavid; Johanna L Hannan; Noel N Kim; Carol A Podlasek; Christopher J Wingard; Arthur L Burnett
Journal:  J Sex Med       Date:  2015-12-08       Impact factor: 3.802

5.  Combination therapy with topical alprostadil and phosphodiesterase-5 inhibitors after failure of oral therapy in patients with erectile dysfunction: a prospective, two-arm, open-label, non-randomized study.

Authors:  Pablo Garrido-Abad; Isabel Senra-Bravo; Celeste Manfredi; Esaú Fernández-Pascual; Estefanía Linares-Espinós; Manuel Fernández-Arjona; David Varillas-Delgado; Juan Ignacio Martínez-Salamanca
Journal:  Int J Impot Res       Date:  2021-01-22       Impact factor: 2.408

6.  Erectile dysfunction as a marker of endocrine and glycemic disorders.

Authors:  R Mazzilli; V Zamponi; S Olana; N Mikovic; D Cimadomo; G Defeudis; A Faggiano
Journal:  J Endocrinol Invest       Date:  2022-04-02       Impact factor: 5.467

7.  Sexual health of male cardiac patients - present status and expectations of patients with coronary heart disease.

Authors:  Dariusz Kałka; Łukasz Karpiński; Jana Gebala; Lesław Rusiecki; Anna Biełous-Wilk; Ewa S Krauz; Magdalena Piłot; Krzysztof Womperski; Małgorzata Rusiecka; Witold Pilecki
Journal:  Arch Med Sci       Date:  2017-01-23       Impact factor: 3.318

8.  Risk factors associated with penile prosthesis infection: systematic review and meta-analysis.

Authors:  Alejandro Carvajal; Johana Benavides; Herney Andrés García-Perdomo; Gerard D Henry
Journal:  Int J Impot Res       Date:  2020-02-03       Impact factor: 2.896

9.  Erectile Dysfunction in Men with and without Lower Urinary Tract Symptoms in Nigeria.

Authors:  Patrick Temi Adegun; Peter Olufemi Areo; Abidemi Solomon; Samuel Ayokunle Dada; Philip Babatunde Adebayo
Journal:  World J Mens Health       Date:  2017-08       Impact factor: 5.400

10.  The Daily Therapy With L-Arginine 2,500 mg and Tadalafil 5 mg in Combination and in Monotherapy for the Treatment of Erectile Dysfunction: A Prospective, Randomized Multicentre Study.

Authors:  Luigi Gallo; Stefano Pecoraro; Pasquale Sarnacchiaro; Mauro Silvani; Gabriele Antonini
Journal:  Sex Med       Date:  2020-03-16       Impact factor: 2.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.